Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression

Neuropsychopharmacology

Volumn 30, Issue 6, 2005, Pages 1181-1186

  Baghai, Thomas C ^a   Di Michele, Flavia ^b   Schüle, Cornelius ^a   Eser, Daniela ^a   Zwanzger, Peter ^a   Pasini, Augusto ^b   Romeo, Elena ^b   Rupprecht, Rainer ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Antidepressant therapy; Electroconvulsive therapy; Major depression; Neuroactive steroids; Neurosteroids; Treatment response

Indexed keywords

3 ALPHA 5 ALPHA TETRAHYDROPROGESTERONE; 3 ALPHA 5 BETA TETRAHYDROPROGESTERONE; 3 BETA 5 ALPHA TETRAHYDROPROGESTERONE; 5 BETA DIHYDROPROGESTERONE; 5ALPHA PREGNANE 3,20 DIONE; NEUROSTEROID; SEROTONIN UPTAKE INHIBITOR; TETRAHYDROPROGESTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMATOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SCORING SYSTEM; STEROID BLOOD LEVEL;

ANESTHESIA; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; PSYCHIATRIC STATUS RATING SCALES; STEROIDS;

EID: 19244387490     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300684     Document Type: Article

References (35)

1. Abrams R (2002a). Electroconvulsive Therapy. Oxford University Press: Oxford, New York.
2. Abrams R (2002b). Stimulus titration and ECT dosing. J ECT 18: 3-9.
3. Altar CA (1999). Neurotrophins and depression. Trends Pharmacol Sci 20: 59-61.
4. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision). APA: Washington, DC.
5. Corpechot C, Collins BE, Carey MP, Tsouros A, Robel P, Fry JP (1997). Brain neurosteroids during the mouse oestrous cycle. Brain Res 766: 276-280.
6. Crawley JN, Glowa JR, Majewska MD, Paul SM (1986). Anxiolytic activity of an endogenous adrenal steroid. Brain Res 398: 382-385.
7. d'Elia G (1970). Unilateral electroconvulsive therapy. Acta Psychiatr Scand Suppl 215: 1-98.
8. d'Elia G, Raotma H (1975). Is unilateral ECT less effective than bilateral ECT? Br J Psychiatry 126: 83-89.
9. ECT-review group (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and metaanalysis. Lancet 361: 799-808.
10. Florkowski CM, Crozier IG, Nightingale S, Evans MJ, Ellis MJ, Joyce P et al (1996). Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy. Clin Endocrinol (Oxf) 44: 163-168.
11. Folkerts HW, Michael N, Tolle R, Schonauer K, Mucke S, Schulze-Monking H (1997). Electroconvulsive therapy vs paroxetine in treatment-resistant depression - a randomized study. Acta Psychiatr Scand 96: 334-342.
12. George MS, Guidotti A, Rubinow D, Pan B, Mikalauskas K, Post RM (1994). CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI. Biol Psychiatry 35: 775-780.
13. Griffin LD, Mellon SH (1999). Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 96: 13512-13517.
14. Grunhaus L, Zelnik T, Albala AA, Rabin D, Haskett RF, Zis AP et al (1987). Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy. J Affect Disord 13: 233-240.
15. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
16. Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P (1985). Efficacy of ECT: a meta-analysis. Am J Psychiatry 142: 297-302.
17. Khisti RT, Chopde CT, Jain SP (2000). Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 67: 137-143.
18. Maitra R, Reynolds JN (1998). Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms. Can J Physiol Pharmacol 76: 909-920.
19. Padberg F, Di Michele F, Zwanzger P, Romeo E, Bernardi G, Schule C et al (2002). Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation in depression. Neuropsychopharmacology 27: 874-878.
20. Paul SM, Purdy RH (1992). Neuroactive steroids. FASEB J 6: 2311-2322.
21. A receptor-complex. Neurosci Lett 135: 273-275.
22. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S et al (1996). Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153: 985-992.
23. Prudic J, Sackeim HA, Devanand DP (1990). Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 31: 287-296.
24. Romeo E, Cheney DL, Zivkovic I, Costa E, Guidotti A (1994). Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone. J Pharmacol Exp Ther 270: 89-96.
25. Romeo E, Strohle A, Spalletta G, Di Michele F, Hermann B, Holsboer F et al (1998). Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155: 910-913.
26. Rupprecht R (2003). Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28: 139-168.
27. Rupprecht R, Holsboer F (1999). Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22: 410-416.
28. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ et al (1993). Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839-846.
29. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S et al (2000). A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57: 425-434.
30. Schule C, Di Michele F, Baghai T, Romeo E, Bernardi G, Zwanzger P et al (2003). Influence of sleep deprivation on neuroactive steroids in major depression. Neuropsychopharmacology 28: 577-581.
31. Smith MA, Zhang LX, Lyons WE, Mamounas LA (1997). Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport 8: 1829-1834.
32. Strohle A, Romeo E, Di Michele F, Pasini A, Yassouridis A, Holsboer F et al (2002). GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry 159: 145-147.
33. Uzunov DP, Cooper TB, Costa E, Guidotti A (1996). Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA 93: 12599-12604.
34. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E et al (1998). Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 95: 3239-3244.
35. Wu JC, Bunney WE (1990). The biological basis of an anti-depressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 147: 14-21.